Lucrative niches: how drugs for rare diseases became lifeline for companies.
Anand
Geeta
G
D001709:Biotechnology / Q000191:economics; D004345:Drug Industry / Q000191:economics*; D005378:Financial Support; D005382:Financing, Personal; D033161:Government Regulation; D006801:Humans; D007349:Insurance, Health, Reimbursement; D008489:Medical Indigency; D009965:Orphan Drug Production / Q000191:economics* / Q000941:ethics / Q000331:legislation & jurisprudence; D035583:Rare Diseases / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration